Endometrial Ablation Devices Market

Endometrial Ablation Devices Market Outlook (2022-2027)

As per a new Fact.MR analysis, the global endometrial ablation device sales are currently valued at around US$ 1.02 billion. Forecasts suggest that the global endometrial ablation devices market will expand at a CAGR of 4% to reach US$ 1.25 billion by 2027.

Sales of endometrial ablation devices are anticipated to be driven by growing use in several medical specialties, including ophthalmology, gynaecology, oncology, and cardiovascular medicine.

Report Attributes	Details
Endometrial Ablation Devices Market Size (2022E)	US$ 1.02 Billion
Forecasted Market Value (2027F)	US$ 1.25 Billion
Global Market Growth Rate (2022-2027)	4% CAGR
China Market Value (2027)	US$ 268 million
Key Companies Profiled	AEGEA Medical, Inc. Boston Scientific Corporation Hologic, Inc. Idoman Teoranta Medtronic Plc. (Smith & Nephew Plc.) Minerva Surgical, Inc. Olympus Corporation Omnitech Systems, Inc. The Cooper Companies, Inc. (CooperSurgical, Inc.) Veldana Medical SA

Endometrial Ablation Device Sales Analysis (2017-2021) Vs. Market Forecasts (2022-2027)

The endometrial lining of the uterus is taken out through an endometrial ablation operation to treat heavy bleeding. By removing these thin layers, endometrium ablation aids in halting abnormally high uterine bleeding.

When uterine hemorrhage is no longer under control with medication, this operation is strongly advised. For those ladies who have conditions such as endometrial hyperplasia, uterine infections, pregnancy, or uterine cancer, this operation is categorically not advised.

Depending on the patient, there are several endometrial ablation procedures available, including heated balloons, heated fluid, radiofrequency, microwave ablation techniques, electro-surgery, and freezing.

Irregular and disorderly heartbeat known as atrial fibrillation is treated through atrial fibrillation (AF) ablation. To stop the malfunctioning electrical signals and re-establish a regular heartbeat, it uses heat or cold energy to form microscopic scars inside the heart.

By stopping the transmission of pain signals, the destruction (also known as ablation) of nerves or neuro ablation devices are used to decrease some types of chronic pain. It is a risk-free treatment in which a little section of nerve tissue is removed or damaged to stop the pain signals and lessen the discomfort in that area.

Catheter ablation using radiofrequency (heat cauterization) and catheter ablation utilising cryoablation (freeze cauterization) are the two forms of cardiac ablation technologies.

When a person has aberrant heart rhythms-where the heart beats too quickly or irregularly-cardiac ablation technologies are used. When this happens, doctors undertake ablation to treat any cardiac conditions that may be causing the irregular heartbeat.

The endometrial ablation devices market is anticipated to develop at a faster rate than average over the forecast period due to factors including rising menorrhagia prevalence, increased awareness of endometrial ablation, and rising demand for minimally invasive procedures.

Development of the market is aided by additional factors such as endometrial ablation's technological advancement and its advantages over surgical techniques. Endometrial ablation also has several benefits over other surgical procedures, including speedier recovery, less pain, minimum invasion, and shorter operation times. These elements contribute to an increase in endometrial ablation device demand globally.

The global endometrial ablation devices market is set to expand at a CAGR of 4% to reach US$ 1.25 billion by 2027, says Fact.MR, a market research and competitive intelligence provider.

What Factors are Influencing Endometrial Ablation Equipment Sales?

“Rising Cases of Gynaecological Problems & Awareness Related to Treatment Procedures Driving Sales of Endometrial Ablation Devices”

Due to the expanding prevalence of gynaecological problems such as menorrhagia, PCOD, irregular vaginal bleeding, and growing public knowledge of endometrial ablation, there is an increased demand for endometrial ablation operations as well as devices.

The development of minimally-invasive endometrial ablation treatments has made it possible to eliminate the endometrium in situ, during a day-care surgery. This operation is easier to do technically and less risky.

• Incidence of abnormal uterine bleeding (AUB) in women of reproductive age ranges from 3 to 30%, and it has a large global impact, according to the International Federation of Gynecology and Obstetrics (FIGO).

Consequently, it is anticipated to fuel market expansion across the board.

• Among women of reproductive age, abnormal uterine bleeding (AUB) is the most prevalent condition. AUB reduces productivity and can require surgical treatment. AUB is said to affect 9 to 14% of women between menarche and menopause, according to the National Health Portal India. The prevalence varies by nation.

The main reasons propelling the global endometrial ablation devices market are the increased demand for less invasive surgical procedures, the prevalence of numerous gynaecological problems, and the increasing female population experiencing abnormal vaginal bleeding.

“Strict Government Product Approval Regulations”

On the flip side, strict government rules for endometrial ablation device approval and endometrial ablation risks are anticipated to restrain market expansion.

What Strategies are Being Adopted by New Market Players?

“New Entrants Focusing on Creating Innovative Endometrial Ablation Products”

To stand out from the competition, new businesses entering the market place a strong emphasis on creating technologically sophisticated ablation systems. Emerging market companies collaborate with important endometrial ablation device manufacturers to sell and distribute their products internationally.

• Over the past few years Meditrina Inc. has launched cutting-edge endometrial ablation devices into the market.

Where are Suppliers of Endometrial Ablation Devices Concentrating On?

“Rapid Technological Advancements in Endometrial Ablation Equipment in North America”

Throughout the forecast period, North America is anticipated to lead the market as a whole. Rapid technological developments were seen in this region's market for endometrial ablation devices.

The endometrial ablation devices market in this region is being driven by increased instances of gynaecological illnesses, a growing healthcare infrastructure, and a strong market participant base that offers cutting-edge endometrial ablation devices.

• For instance, the FDA imposed restrictions on the marketing and distribution of Essure, a female sterilisation device, in April 2018. This was done to make certain that all women have access to sufficient risk information to make wise judgments.

By 2027, the market for endometrial ablation devices in Europe will generate a sizable amount of revenue due to the developed healthcare systems in nations such as Germany, Italy, and the UK, particularly in terms of hospital beds, skilled personnel, and infrastructure.

• Also, the National Health Service reports that every year in the U.K., almost 260 women are diagnosed with vaginal cancer.

These elements are anticipated to fuel the regional market outlook in the coming years, coupled with rising healthcare costs and the high frequency of cervical cancer in nations such as the UK and France.

The market is anticipated to expand significantly in the Asia Pacific during the anticipated timeframe. The COVID-19 outbreak has brought attention to the region's health system's shortcomings and inadequacies, as well as the interconnection between economic stability and health security.

The region is therefore moving closer to achieving Universal Health Care, or UHC, as a result. In addition, the market is anticipated to grow as menorrhagia is becoming more common and as demand for cutting-edge technologies rises.

The market for endometrial ablation devices in the Asia Pacific is also expected to expand due to an increase in ambulatory surgery centers and the availability of improved endometrial ablation technologies among clinics.

Country-wise Analysis

What is Supporting Sales of Endometrial Ablation Devices in the U.S.?

“Rising Cases of Endometriosis Driving Demand for Endometrial Ablation Devices”

• The U.S. Department of Health and Human Services estimates that 11% of American women experience endometriosis, which causes inflammation when the tissue reacts to a woman's monthly menstrual cycle variations.

According to this data, the nation’s growing medical cases and sizable patient pool are driving market expansion.

Patient health outcomes and safety are of the utmost significance in the United States, and numerous initiatives have been formed to raise healthcare quality and cut costs. Another driver fueling the market's expansion in the United States is its high healthcare spending.

How is the Market for Endometrial Ablation Devices Progressing in India?

“Rising Cases Related to AUB Fuelling Endometrial Ablation Device Demand”

Governments and private organisations throughout the world place a high priority on the health of women. Women's health insurance plans are one of the key factors anticipated to propel the sector in developed nations.

For instance, the income tax deduction that may be claimed on premiums paid for health insurance policies is one of many tax benefits and exemptions that are available to women in India under various sections of the income tax legislation. Such women's health activities may enhance the use of the existing treatment alternatives, hence promoting the market growth.

Among women of reproductive age, abnormal uterine bleeding (AUB) is the most prevalent condition. In India, the frequency of AUB has been calculated to be around 18%. Thus, the above-mentioned factors are expected to boost endometrial ablation device sales.

Category-wise Analysis

Which Product Type is Exhibiting High Demand?

“Radiofrequency Ablation Equipment Highly Demanded Due to Multiple Benefits”

Among the product types, the highest market share is expected to account for radiofrequency ablation devices, and this may be attributed to aspects such as high safety & quick recovery, growing awareness of this treatment in developing nations, and high preference from many medical professionals.

Increasing prevalence of menorrhagia, cervical cancer, and other gynaecological illnesses are the main drivers driving the segment growth, in addition to the benefits of the devices.

The product's ease, treatment-time efficiency, effectiveness, and cost-effectiveness in comparison to alternative ablation devices are what drive the market growth. Furthermore, radiofrequency ablation equipment is widely accessible and well-known among doctors.

Competitive Landscape

A majority of manufacturers are concentrating on purchasing technologies created by rivals to expand their product line. Despite the market for endometrial ablation devices being consolidated, new competitors are entering it by releasing a variety of endometrial ablation products and accessories.

• For over US$ 350 million, Medtronic plc purchased Smith & Nephew's gynaecological division in 2016. Through this agreement, Medtronic acquired TRUCLEAR System, a crucial gynaecological product from Smith & Nephew.
• In 2019, following Aveta's FDA approval, ShangBay Capital LLC and Aethan Capital, Inc. organized a US$ 13 million equity funding round for Meditrina Inc. This illustrates the market for hysteroscopy systems' growth potential during the anticipated term.

Segments of Endometrial Ablation Devices Industry Research

• By Product :

  • Radiofrequency Endometrial Ablation
  • Cryoablation
  • Hydrothermal Ablation
  • Thermal Balloon Ablation
  • Hysteroscopy Devices

• By End User :

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

• By Region :

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Oceania
  • MEA